Mass spectrometry-based protein biomarker analysis in chemoimmunotherapy combinations identifies unique immune signatures in pancreatic cancer - Biognosys

Mass spectrometry-based protein biomarker analysis in chemoimmunotherapy combinations identifies unique immune signatures in pancreatic cancer

Poster presented at the AACR Annual Meeting 2023

Presenter: Nigel Beaton

Acknowledgment: Parker Institute for Cancer Immunotherapy (PICI)
Poster Presentation Number: 5300

Back to Resources overview

Contact

    Close banner

    New: Spectronaut® 18

    Limitless Throughput. Unparalleled Efficiency

    New: Spectronaut® 18

    Limitless Throughput. Unparalleled Efficiency.

    Learn More